Skip to main content
Duke University Libraries
DukeSpace Scholarship by Duke Authors
  • Login
  • Ask
  • Menu
  • Login
  • Ask a Librarian
  • Search & Find
  • Using the Library
  • Research Support
  • Course Support
  • Libraries
  • About
View Item 
  •   DukeSpace
  • Theses and Dissertations
  • Undergraduate Honors Theses and Student papers
  • View Item
  •   DukeSpace
  • Theses and Dissertations
  • Undergraduate Honors Theses and Student papers
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

What Have We GAINed? An Analysis of Federal Incentive Policies in the Orphan and Anti-Infective Drug Markets

Thumbnail
View / Download
769.8 Kb
Date
2016-01-27
Author
Hoerger, Ryan
Advisor
Angrist, Misha
Repository Usage Stats
666
views
525
downloads
Abstract
The world faces a growing danger in the form of antibiotic resistance and a dwindling anti-infective pipeline. To help combat the threat, Congress passed legislation (the “GAIN Act”) in 2012 that grants five years of additional exclusivity—or protection from competition from generic products—to drug applications that are designated as qualified infectious disease products (QIDPs). The exclusivity incentive is nearly a carbon copy of the hallmark design of the 1983 Orphan Drug Act, which was passed to spur development of treatments for rare diseases. This thesis addresses the effectiveness of incentive policies in facilitating drug development in the orphan drug market for rare diseases and the anti-infective drug market. Using pricing data from Medicare Part D program and drug databases, the research develops frameworks for both the orphan and anti-infective markets and finds that the two markets vary widely across all measured categories. During the course of the past decade, anti-infectives became less of a priority in the development pipelines of the world’s top pharmaceutical companies, and content analysis of earnings call transcripts reveals that industry executives do not seem to be discussing the new incentive. The results indicate that a new or augmented approach to anti-infectives may be needed. Instead of using exclusivity, the government should consider offering benefits that companies realize at the front end of the research and development pipeline as a means to increase drug development in the anti-infective drug market.
Type
Honors thesis
Department
Public Policy Studies
Subject
anti-infective
GAIN
Congress
Orphan Drug Act
antibiotics
Permalink
https://hdl.handle.net/10161/11543
Citation
Hoerger, Ryan (2016). What Have We GAINed? An Analysis of Federal Incentive Policies in the Orphan and Anti-Infective Drug Markets. Honors thesis, Duke University. Retrieved from https://hdl.handle.net/10161/11543.
Collections
  • Undergraduate Honors Theses and Student papers
More Info
Show full item record
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.

Rights for Collection: Undergraduate Honors Theses and Student papers


Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info

Make Your Work Available Here

How to Deposit

Browse

All of DukeSpaceCommunities & CollectionsAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit DateThis CollectionAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit Date

My Account

LoginRegister

Statistics

View Usage Statistics
Duke University Libraries

Contact Us

411 Chapel Drive
Durham, NC 27708
(919) 660-5870
Perkins Library Service Desk

Digital Repositories at Duke

  • Report a problem with the repositories
  • About digital repositories at Duke
  • Accessibility Policy
  • Deaccession and DMCA Takedown Policy

TwitterFacebookYouTubeFlickrInstagramBlogs

Sign Up for Our Newsletter
  • Re-use & Attribution / Privacy
  • Harmful Language Statement
  • Support the Libraries
Duke University